The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantifying the clinical impact of tissue reflex testing for liquid biopsy ESR1 mutation–negative cases with low ctDNA tumor fraction (TF) in HR(+)HER2(-) breast cancer.
 
Jing Du
No Relationships to Disclose
 
Julia Quintanilha
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Foundation Medicine
 
Richard Huang
Employment - Roche/Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Patent on IHC; provisional patent on biomarkers and biomarker methodology.
 
Andreas Heilmann
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Adriana Kahn
Consulting or Advisory Role - Pfizer
 
Mariya Rozenblit
Consulting or Advisory Role - AstraZeneca
 
Anne Chiang
Consulting or Advisory Role - Abbvie; Abbvie; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; BMS; Boehringer Ingelheim; Catalyst Pharmaceuticals; Daichi; Flatiron Health; Fosun Pharma; Genentech; Genentech; Genentech; Genentech/Roche; Janssen Oncology; Jazz Pharmaceuticals; Jazz Pharmaceuticals; regeneron; Sanofi/Regeneron; Zai Lab
Research Funding - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Millennium; OncoMed; Onyx; Stem CentRx; Zai Lab
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Genentech/Roche
 
Lajos Pusztai
Stock and Other Ownership Interests - Ataraxis
Honoraria - Agendia; AstraZeneca; Bristol-Myers Squibb; Merck @ Co; natera; Radionetics
Consulting or Advisory Role - Agendia; AstraZeneca; Bristol Myers Squibb; Merck; Natera; Personalis; Radionetics
Research Funding - Agendia (Inst); AstraZeneca (Inst); Bristol Myers Squibb (Inst); Exact Sciences (Inst); Menarini (Inst); Merck (Inst); Natera (Inst); Personalis (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Foundation Medicine
 
Ian Krop
Employment - PureTech (I)
Leadership - PureTech (I)
Stock and Other Ownership Interests - PureTech (I)
Honoraria - AstraZeneca; Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genentech/Roche; Merck; Merck KGaA; Novartis; Seagen
Research Funding - Genentech (Inst); Macrogenics (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - anti-murine CD19 monoclonal antibody licensed to PharMingen
 
Eric Winer
No Relationships to Disclose
 
Ryon Graf
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Epic Sciences; Foundation Medicine
 
Jennifer Mills
Employment - Foundation Medicine; Genentech/Roche
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Merck; Roche
 
Amaya Gasco Hernandez
Employment - Foundation Medicine; Kura Oncology
Leadership - Foundation Medicine; Kura Oncology
Stock and Other Ownership Interests - AstraZeneca; Kura Oncology; Roche
 
Mia Levy
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Royalties from GenomOncology for licensing of MyCancerGenome content
 
Maryam Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Menarini; Novartis; Osmol Therapeutics; Pfizer
Speakers' Bureau - Lilly
Other Relationship - Cynosure/Hologic